Prevention Strategies to Minimize the Infection Risk Associated With Biologic and Targeted Immunomodulators

Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s233137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PDB31 Targeted Cost Saving Strategies in Diabetes Prevention Using Risk Stratification

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Risk Factors and Prevention Strategies of Nosocomial Infection in Geriatric Patients

Canadian Journal of Infectious Diseases and Medical Microbiology
Infectious DiseasesMicrobiology
2019English

Prevention Strategies for HIV Infection Risk Reduction Among Hispanic/Latino Adolescents

2011English

Host Response to Human Rhinovirus Infection: Toward Targeted Treatment Strategies

Future Virology
Virology
2009English

The Risk of Hypersensitivity Associated With Biologic Use Among Medicare Patients With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2017English

Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection

Journal of Histochemistry and Cytochemistry
AnatomyHistology
2018English

Strategies to Prevent Catheter-Associated Urinary Tract Infection

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2009English

Making Infection Prevention Education Interactive Can Enhance Knowledge and Improve Outcomes: Results From the Targeted Infection Prevention (TIP) Study

American Journal of Infection Control
EpidemiologyPublic HealthHealth PolicyInfectious DiseasesEnvironmentalOccupational Health
2016English

Healthcare Associated Infection: Novel Strategies and Antimicrobial Implants to Prevent Surgical Site Infection

Annals of the Royal College of Surgeons of England
MedicineSurgery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy